India Weighing Options To Cap Device Prices
This article was originally published in PharmAsia News
Executive Summary
Faced with mounting pressure from politicians, Indian regulators are scrutinizing the pricing data of several device makers to check the number of increases over a two year time frame. Many believe this could be a precursor to a pricing cap for widely used devices, primarily cardiac stents.